Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · Real-Time Price · USD
90.73
+0.99 (1.10%)
At close: Dec 20, 2024, 4:00 PM
91.00
+0.27 (0.30%)
After-hours: Dec 20, 2024, 4:52 PM EST

Axsome Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
4,3973,7663,3491,4243,0423,805
Upgrade
Market Cap Growth
30.79%12.44%135.22%-53.20%-20.03%4425.27%
Upgrade
Enterprise Value
4,2623,5353,2161,3592,8883,781
Upgrade
Last Close Price
90.7379.5977.1337.7881.47103.36
Upgrade
PS Ratio
12.7613.9266.94---
Upgrade
PB Ratio
47.3119.7230.5791.1026.7421.29
Upgrade
P/TBV Ratio
133.3329.9784.6191.1026.7421.29
Upgrade
EV/Sales Ratio
12.5913.0664.28---
Upgrade
Debt / Equity Ratio
2.070.980.863.180.440.11
Upgrade
Asset Turnover
0.580.590.24---
Upgrade
Inventory Turnover
2.492.68----
Upgrade
Quick Ratio
2.303.462.473.757.858.98
Upgrade
Current Ratio
2.443.632.543.757.859.00
Upgrade
Return on Equity (ROE)
-171.61%-159.21%-298.97%-201.51%-70.36%-76.08%
Upgrade
Return on Assets (ROA)
-26.44%-24.86%-52.29%-56.91%-30.46%-35.55%
Upgrade
Return on Capital (ROIC)
-41.52%-39.31%-81.33%-68.00%-34.16%-40.62%
Upgrade
Earnings Yield
-7.07%-6.35%-5.59%-9.16%-3.38%-1.80%
Upgrade
FCF Yield
-3.02%-3.87%-3.50%-7.62%-2.58%-1.22%
Upgrade
Buyback Yield / Dilution
-7.10%-11.73%-8.07%-1.11%-9.37%-26.55%
Upgrade
Total Shareholder Return
-7.10%-11.73%-8.07%-1.11%-9.37%-26.55%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.